Discordance Between Clinical and Pathological Staging and Grading in Upper Tract Urothelial Carcinoma

Standard

Discordance Between Clinical and Pathological Staging and Grading in Upper Tract Urothelial Carcinoma. / Mori, Keiichiro; Katayama, Satoshi; Laukhtina, Ekaterina; Schuettfort, Victor M; Pradere, Benjamin; Quhal, Fahad; Sari Motlagh, Reza; Mostafaei, Hadi; Grossmann, Nico C; Rajwa, Pawel; Zimmermann, Kristin; Karakiewicz, Pierre I; Abufaraj, Mohammad; Fajkovic, Harun; Rouprêt, Morgan; Margulis, Vitaly; Enikeev, Dmitry V; Egawa, Shin; Shariat, Shahrokh F.

In: CLIN GENITOURIN CANC, Vol. 20, No. 1, 02.2022, p. 95.e1-95.e6.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Mori, K, Katayama, S, Laukhtina, E, Schuettfort, VM, Pradere, B, Quhal, F, Sari Motlagh, R, Mostafaei, H, Grossmann, NC, Rajwa, P, Zimmermann, K, Karakiewicz, PI, Abufaraj, M, Fajkovic, H, Rouprêt, M, Margulis, V, Enikeev, DV, Egawa, S & Shariat, SF 2022, 'Discordance Between Clinical and Pathological Staging and Grading in Upper Tract Urothelial Carcinoma', CLIN GENITOURIN CANC, vol. 20, no. 1, pp. 95.e1-95.e6. https://doi.org/10.1016/j.clgc.2021.10.002

APA

Mori, K., Katayama, S., Laukhtina, E., Schuettfort, V. M., Pradere, B., Quhal, F., Sari Motlagh, R., Mostafaei, H., Grossmann, N. C., Rajwa, P., Zimmermann, K., Karakiewicz, P. I., Abufaraj, M., Fajkovic, H., Rouprêt, M., Margulis, V., Enikeev, D. V., Egawa, S., & Shariat, S. F. (2022). Discordance Between Clinical and Pathological Staging and Grading in Upper Tract Urothelial Carcinoma. CLIN GENITOURIN CANC, 20(1), 95.e1-95.e6. https://doi.org/10.1016/j.clgc.2021.10.002

Vancouver

Bibtex

@article{775ab30ca86e4c2c8804bb5c9ab493d6,
title = "Discordance Between Clinical and Pathological Staging and Grading in Upper Tract Urothelial Carcinoma",
abstract = "INTRODUCTION: This study aimed to evaluate the concordance in tumor stage and grade between ureteroscopic (URS) biopsy and radical nephroureterectomy (RNU) in patients with upper tract urothelial carcinoma (UTUC).PATIENTS AND METHODS: Records of 1,214 UTUC patients who had undergone URS biopsy followed by RNU were included. Univariable and multivariable logistic regression analyses were performed to identify factors contributing to the pathological upstaging.RESULTS: The concordance between URS biopsy-based clinical and RNU pathological staging was 34.5%. Clinical understaging occurred in 59.5% patients. Upstaging to muscle-invasive disease occurred in 240 (41.7%) of 575 patients diagnosed with ≤cT1 disease. Of those diagnosed with muscle-invasive disease on final pathology, 89.6% had been clinically diagnosed with ≤cT1 disease. In the univariable analyses, computed tomography urography (CTU)-based invasion, ureter location, hydronephrosis, high-grade cytology, high-grade biopsy, sessile architecture, age, and women sex were significantly associated with pathological upstaging (P < .05). In the multivariable analyses, CTU-based invasion and hydronephrosis remained associated with pathological upstaging (P < .05). URS biopsy-based clinical and pathological gradings were concordant in 634 (54.2%) patients. Clinical undergrading occurred in 496 (42.4%) patients.CONCLUSIONS: Clinical understaging/undergrading and upstaging to muscle-invasive disease occurred in a high proportion of UTUC patients undergoing RNU. Despite the inherent selection bias, these data underline the challenges of accurate UTUC staging and grading. In daily clinical practice, URS biopsy and CTU offer the most accurate preoperative information albeit with limited predictive value when used alone. These findings should be considered when utilizing preoperative, risk-adapted strategies.",
author = "Keiichiro Mori and Satoshi Katayama and Ekaterina Laukhtina and Schuettfort, {Victor M} and Benjamin Pradere and Fahad Quhal and {Sari Motlagh}, Reza and Hadi Mostafaei and Grossmann, {Nico C} and Pawel Rajwa and Kristin Zimmermann and Karakiewicz, {Pierre I} and Mohammad Abufaraj and Harun Fajkovic and Morgan Roupr{\^e}t and Vitaly Margulis and Enikeev, {Dmitry V} and Shin Egawa and Shariat, {Shahrokh F}",
note = "Copyright {\textcopyright} 2021. Published by Elsevier Inc.",
year = "2022",
month = feb,
doi = "10.1016/j.clgc.2021.10.002",
language = "English",
volume = "20",
pages = "95.e1--95.e6",
journal = "CLIN GENITOURIN CANC",
issn = "1558-7673",
publisher = "Elsevier",
number = "1",

}

RIS

TY - JOUR

T1 - Discordance Between Clinical and Pathological Staging and Grading in Upper Tract Urothelial Carcinoma

AU - Mori, Keiichiro

AU - Katayama, Satoshi

AU - Laukhtina, Ekaterina

AU - Schuettfort, Victor M

AU - Pradere, Benjamin

AU - Quhal, Fahad

AU - Sari Motlagh, Reza

AU - Mostafaei, Hadi

AU - Grossmann, Nico C

AU - Rajwa, Pawel

AU - Zimmermann, Kristin

AU - Karakiewicz, Pierre I

AU - Abufaraj, Mohammad

AU - Fajkovic, Harun

AU - Rouprêt, Morgan

AU - Margulis, Vitaly

AU - Enikeev, Dmitry V

AU - Egawa, Shin

AU - Shariat, Shahrokh F

N1 - Copyright © 2021. Published by Elsevier Inc.

PY - 2022/2

Y1 - 2022/2

N2 - INTRODUCTION: This study aimed to evaluate the concordance in tumor stage and grade between ureteroscopic (URS) biopsy and radical nephroureterectomy (RNU) in patients with upper tract urothelial carcinoma (UTUC).PATIENTS AND METHODS: Records of 1,214 UTUC patients who had undergone URS biopsy followed by RNU were included. Univariable and multivariable logistic regression analyses were performed to identify factors contributing to the pathological upstaging.RESULTS: The concordance between URS biopsy-based clinical and RNU pathological staging was 34.5%. Clinical understaging occurred in 59.5% patients. Upstaging to muscle-invasive disease occurred in 240 (41.7%) of 575 patients diagnosed with ≤cT1 disease. Of those diagnosed with muscle-invasive disease on final pathology, 89.6% had been clinically diagnosed with ≤cT1 disease. In the univariable analyses, computed tomography urography (CTU)-based invasion, ureter location, hydronephrosis, high-grade cytology, high-grade biopsy, sessile architecture, age, and women sex were significantly associated with pathological upstaging (P < .05). In the multivariable analyses, CTU-based invasion and hydronephrosis remained associated with pathological upstaging (P < .05). URS biopsy-based clinical and pathological gradings were concordant in 634 (54.2%) patients. Clinical undergrading occurred in 496 (42.4%) patients.CONCLUSIONS: Clinical understaging/undergrading and upstaging to muscle-invasive disease occurred in a high proportion of UTUC patients undergoing RNU. Despite the inherent selection bias, these data underline the challenges of accurate UTUC staging and grading. In daily clinical practice, URS biopsy and CTU offer the most accurate preoperative information albeit with limited predictive value when used alone. These findings should be considered when utilizing preoperative, risk-adapted strategies.

AB - INTRODUCTION: This study aimed to evaluate the concordance in tumor stage and grade between ureteroscopic (URS) biopsy and radical nephroureterectomy (RNU) in patients with upper tract urothelial carcinoma (UTUC).PATIENTS AND METHODS: Records of 1,214 UTUC patients who had undergone URS biopsy followed by RNU were included. Univariable and multivariable logistic regression analyses were performed to identify factors contributing to the pathological upstaging.RESULTS: The concordance between URS biopsy-based clinical and RNU pathological staging was 34.5%. Clinical understaging occurred in 59.5% patients. Upstaging to muscle-invasive disease occurred in 240 (41.7%) of 575 patients diagnosed with ≤cT1 disease. Of those diagnosed with muscle-invasive disease on final pathology, 89.6% had been clinically diagnosed with ≤cT1 disease. In the univariable analyses, computed tomography urography (CTU)-based invasion, ureter location, hydronephrosis, high-grade cytology, high-grade biopsy, sessile architecture, age, and women sex were significantly associated with pathological upstaging (P < .05). In the multivariable analyses, CTU-based invasion and hydronephrosis remained associated with pathological upstaging (P < .05). URS biopsy-based clinical and pathological gradings were concordant in 634 (54.2%) patients. Clinical undergrading occurred in 496 (42.4%) patients.CONCLUSIONS: Clinical understaging/undergrading and upstaging to muscle-invasive disease occurred in a high proportion of UTUC patients undergoing RNU. Despite the inherent selection bias, these data underline the challenges of accurate UTUC staging and grading. In daily clinical practice, URS biopsy and CTU offer the most accurate preoperative information albeit with limited predictive value when used alone. These findings should be considered when utilizing preoperative, risk-adapted strategies.

U2 - 10.1016/j.clgc.2021.10.002

DO - 10.1016/j.clgc.2021.10.002

M3 - SCORING: Journal article

C2 - 34764007

VL - 20

SP - 95.e1-95.e6

JO - CLIN GENITOURIN CANC

JF - CLIN GENITOURIN CANC

SN - 1558-7673

IS - 1

ER -